Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00056953 · ClinicalTrials.gov registry record · Phase 2
Peer Mentors for Adolescents in HIV Affected Families
A Phase 2 study of Health Behavior and Adolescent Behavior, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- Completed
- Registry status
- Phase 2
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT00056953: Completed Phase 2 study of Health Behavior and Adolescent Behavior, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
NCT00056953 is a Phase 2 study of Health Behavior and Adolescent Behavior that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 160 participants, below the 2,183-participant average among 65 other Health Behavior trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00056953, a Phase 2 study of Health Behavior and Adolescent Behavior, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the effectiveness of a peer mentoring program designed for youths ages 9 to 15 whose parents or guardians are HIV infected. The program will focus on the youths' mental health, school performance, alcohol and drug use, personal and social behaviors, and behaviors that might expose them to HIV. The study is expected to enroll predominantly minority youth.
Conditions Studied
Interventions
- BEHAVIORAL Peer mentoring program
Study Locations (1)
New York
- Health People - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 1999-09 |
| Est. Completion | 2004-11 |
| Phase | Phase 2 |
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)305 total trials
What the finished NCT00056953 record still lists
NCT00056953 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 2,183-participant average among 65 other Health Behavior trials with a reported enrollment target (93% lower).
The record links to 3 conditions, with Health Behavior appearing as the primary indexed condition, and to 1 intervention - of which Peer mentoring program is the first listed.
NCT00056953 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00056953 about?
NCT00056953 is a clinical study titled "Peer Mentors for Adolescents in HIV Affected Families". This study will evaluate the effectiveness of a peer mentoring program designed for youths ages 9 to 15 whose parents or guardians are HIV infected. The program will focus on the youths' mental health, school performance, alcohol and drug use, personal and social behaviors, and behaviors that might ...
What is the current status of trial NCT00056953?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 160 participants. The study started on 1999-09. Estimated completion is 2004-11.
What conditions does trial NCT00056953 study?
This clinical trial studies the following conditions: Health Behavior, Adolescent Behavior, HIV Seronegativity.
What interventions are being tested in trial NCT00056953?
The interventions under investigation include: Peer mentoring program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00056953?
This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00056953 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Health Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00056953's enrollment target sits among peer trials
160 36th of 65 higher than 30 of 65 other Health Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Health Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sugary Drink Labeling Study
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
The Lake Nona Life Project
RECRUITING
-
The Validation Study of Bioelectronics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia